Harel Insurance Investments & Financial Services Ltd. Biomarin Pharmaceutical Inc Transaction History

Harel Insurance Investments & Financial Services Ltd.

  • $5.31 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 26, 2021
SELL
$72.61 - $90.2 $14,522 - $18,040
-200 Closed
0 $0
Q3 2020

Oct 20, 2020
BUY
$71.87 - $131.03 $14,374 - $26,206
200 New
200 $15,000
Q4 2018

Jan 29, 2019
SELL
$80.14 - $106.07 $308,218 - $407,945
-3,846 Closed
0 $0
Q3 2018

Oct 29, 2018
SELL
$93.92 - $105.72 $164,735 - $185,432
-1,754 Reduced 31.32%
3,846 $373,000
Q2 2018

Jul 30, 2018
BUY
$76.01 - $99.03 $425,656 - $554,568
5,600 New
5,600 $528,000

Others Institutions Holding BMRN

# of Institutions
632
Shares Held
185M
Call Options Held
1.63M
Put Options Held
1.2M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $13.1B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Harel Insurance Investments & Financial Services Ltd. Portfolio

Follow Harel Insurance Investments & Financial Services Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email